E-z-paque Powder, For Suspension
Product Images NDC 32909-750

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for E-z-paque (NDC 32909-750). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by E-z-em Canada Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Barium-sulfate-structure (Barium Sulfate Structure)

Chemical structure of barium sulfate showing a barium ion (Ba2+) and a sulfate ion (SO4) with two negative charges.*

FDA Label Image

E-z-paque-external-label (E Z Paque External Label)

E-Z-Paque powder for suspension, 169 g per single dose bottle, containing 96% w/w barium sulfate for oral suspension. The label indicates use for radiographic examinations of the esophagus, stomach, duodenum, and small bowel. Manufactured by E-Z-EM Canada Inc for Bracco Diagnostics. The package includes 24 bottles of 176 g each.*

FDA Label Image

E-z-paque-internal-label (E Z Paque Internal Label)

E-Z-Paque 960 mg/g (barium sulfate) powder for oral suspension label. The label includes the Bracco Diagnostics logo and states the product is a single-dose bottle for oral use only in contrast upper GI studies. It lists inactive ingredients and instructions to use immediately after reconstitution. Manufactured by E-Z-EM Canada Inc for Bracco Diagnostics Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.